Protease-Activated Receptor 2 Attenuates Doxorubicin-Induced Apoptosis in Colon Cancer Cells

Scientists investigated a possible mechanistic link between PAR2 activation of intracellular signaling and pro-survival events in HT29 human colon cancer cells, then identified possible strategies to restore doxorubicin effects.